NEIS JOHN 4
4 · Cellectar Biosciences, Inc. · Filed Mar 19, 2021
Insider Transaction Report
Form 4
NEIS JOHN
Director
Transactions
- Sale
Series A Warrants
2021-03-17$0.28/sh−58,640$16,273→ 23,232 totalExercise: $30.40From: 2016-04-20Exp: 2021-04-20→ Common Stock (5,864 underlying) - Sale
Series A Warrants
2021-03-18$0.25/sh−23,232$5,859→ 0 totalExercise: $30.40From: 2016-04-20Exp: 2021-04-20→ Common Stock (2,323 underlying)
Footnotes (2)
- [F1]The price reported is a weighted average price. These warrants were sold in multiple transactions at prices ranging from $0.27 and $0.2845, inclusive. The reporting person undertakes to provide the staff of the Securities and Exchange Commission, upon request, full information regarding the number of warrants sold at each separate price within the ranges set forth in footnote (1) to this Form 4.
- [F2]The price reported is a weighted average price. These warrants were sold in multiple transactions at prices ranging from $0.24 and $0.27, inclusive. The reporting person undertakes to provide the staff of the Securities and Exchange Commission, upon request, full information regarding the number of warrants sold at each separate price within the ranges set forth in footnote (2) to this Form 4.